Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1174)	7/1/2005 10:54:58 AM
From: Jibacoa	Read Replies (2) of 3722

HITK Is making another 52wks. H It is up more than 4% today. bigcharts.marketwatch.com In February it submitted an ANDA for its nasal steroid spray.If the application is approved it will probably be first to market . "It's really a new generic product line for everyone, because no one's been granted generic approval for a steroidal nasal spray," said William Peters,HITK's CFO. GSK had $1.06B in sales of Flonase last year.HITK's total revenue in 2004 was only around 56M. In the 3rd Q it reported 17% better revenues and 58% better earnings and the results for the 4th Q(April), which are due next month will probably show a good comparison since in 2004 earnings were 12% less than 1n 2003 in spite of slightly better revenues. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next